Myomo logo
Myomo MYO
$ 1.67 2.45%
report update icon

Quarterly report 2026-Q2
added 08-05-2026

Myomo Cash Flow 2025-2011 | MYO

Brief overview of Myomo's cash movements

The comparison covers five available annual reports between 2021 and 2025.

At the end of the period, operations consumed -$14.5 million rather than generating cash. This profile calls for caution.

Core operations generated cash in 0 of five years. Frequent negative periods raise financial risk.

Operating cash flow margin improved from -68.9% to -35.5%. The quality of revenue growth strengthened.

An additional $3.7 million became tied up in estimated working capital, equal to 9% of revenue.

Overall picture

Myomo's cash profile looks stretched: weak operating cash flow limits investment, payouts and debt-servicing capacity.

Annual Cash Flow Myomo

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-14.5 M -3.29 M -6.17 M -10.2 M -9.55 M -9.03 M -10.3 M -9.61 M -6.15 M -3.2 M - - - - -

Depreciation & Amortization

859 K 206 K 164 K 193 K 146 K 105 K 95.1 K 69.7 K 11.4 K 7.73 K - - - - -

Accounts Payables

1.51 M 1.17 M 1.07 M 570 K 723 K 180 K 450 K 427 K 265 K - - - - - -

Accounts Receivables

4.1 M 3.83 M 2.38 M 1.9 M 1.96 M 925 K 424 K 382 K 297 K - - - - - -

Total Inventories

3.12 M 3.17 M 1.8 M 1.4 M 808 K 707 K 440 K 256 K 201 K - - - - - -

All numbers in USD currency

Quarterly Cash Flow Myomo

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

-4.14 M -2.2 M - - -2.68 M - - - -3.25 M - - - -1.82 M - -7.77 M - -2.32 M - -7.72 M - -2.11 M - -7.88 M -6.11 M -2.45 M - -7.7 M -5.41 M -3.12 M - -7.09 M -4.61 M -2.27 M - -4.61 M -2.75 M -1.16 M - -2.3 M -984 K - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

676 K 292 K - - 158 K - - - 29.7 K - - - 48.6 K - 144 K - 45.6 K - 95.2 K - 23.3 K - 79.7 K 53 K 26.4 K - 70.7 K 45.1 K 21.6 K - 48.8 K 28.9 K 14.6 K - 6.98 K 4.55 K 2.17 K - 5.86 K 4 K - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

1.25 M 1.81 M 1.62 M 2.51 M 2.49 M 1.17 M 1.3 M 1.37 M 829 K 1.07 M 1.22 M 767 K 907 K 570 K 879 K - 1.01 M 723 K 624 K 612 K 714 K 180 K 180 K 180 K 180 K 450 K 450 K 450 K 450 K 427 K 427 K 427 K 427 K 265 K 265 K 265 K 265 K 311 K - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

4.95 M 4.82 M 5.29 M 7.05 M 4.66 M 3.83 M 3.73 M 2.53 M 1.68 M 2.38 M 2.52 M 1.64 M 1.55 M 1.9 M 1.6 M - 1.69 M 1.96 M 2.22 M 1.13 M 765 K 925 K 925 K 925 K 925 K 424 K 424 K 424 K 424 K 382 K 382 K 382 K 382 K 297 K 297 K 297 K 297 K 115 K 115 K 115 K - - - - - - - - - - - - - - - - - - - - -

Total Inventories

3.17 M 3.55 M 3.65 M 4.13 M 3.37 M 3.17 M 3.38 M 2.6 M 2.39 M 1.8 M 1.48 M 1.34 M 1.57 M 1.4 M 1.48 M - 1.03 M 808 K 644 K 729 K 794 K 707 K 707 K 707 K 707 K 440 K 440 K 440 K 440 K 256 K 256 K 256 K 256 K 201 K 201 K 201 K 201 K 82.4 K 82.4 K 82.4 K - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Myomo, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
- - $ 140 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 100.1 2.67 % $ 174 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 6.53 1.16 % $ 4.4 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 5.74 2.5 % $ 776 M usaUSA
Align Technology Align Technology
ALGN
$ 140.65 0.1 % $ 10.2 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.6 1.96 % $ 107 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.3 7.37 % $ 36.8 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.72 6.88 % $ 1.61 B usaUSA
AxoGen AxoGen
AXGN
$ 37.22 0.21 % $ 1.71 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 9.38 4.8 % $ 2.32 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 379.82 2.89 % $ 10.4 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 63.86 0.98 % $ 9.69 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 42.4 0.31 % $ 62.8 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.77 0.34 % $ 639 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.52 5.74 % $ 326 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 47.33 2.25 % $ 1.47 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 3.97 0.12 % $ 247 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 15.87 4.89 % $ 568 M usaUSA
Electromed Electromed
ELMD
$ 28.32 0.78 % $ 234 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 66.47 3.76 % $ 1.97 B costa-ricaCosta-rica
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 87.23 2.44 % $ 51 B usaUSA
Globus Medical Globus Medical
GMED
$ 76.57 1.28 % $ 10.4 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.65 0.76 % $ 58.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.29 4.81 % $ 1.02 B usaUSA
Inogen Inogen
INGN
$ 5.94 0.34 % $ 158 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.13 0.28 % $ 913 M israelIsrael
Inspire Medical Systems Inspire Medical Systems
INSP
$ 70.75 1.11 % $ 2.08 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.69 7.28 % $ 11.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 86.47 1.25 % $ 1.1 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.45 0.1 % $ 4.39 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 22.89 3.29 % $ 537 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 76.43 1.81 % $ 4.17 B britainBritain
LENSAR LENSAR
LNSR
$ 6.67 0.59 % $ 79.8 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.88 2.73 % $ 76.5 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 87.97 1.88 % $ 113 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.55 0.54 % $ 672 M usaUSA